56 related articles for article (PubMed ID: 8439971)
1. In vitro and in vivo targeting of gene expression to melanoma cells.
Vile RG; Hart IR
Cancer Res; 1993 Mar; 53(5):962-7. PubMed ID: 8439971
[TBL] [Abstract][Full Text] [Related]
2. Promoters with cancer cell-specific activity for melanoma gene therapy.
Pleshkan VV; Alekseenko IV; Zinovyeva MV; Vinogradova TV; Sverdlov ED
Acta Naturae; 2011 Apr; 3(2):13-21. PubMed ID: 22649681
[TBL] [Abstract][Full Text] [Related]
3. Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene.
Sabet S; George MA; El-Shorbagy HM; Bassiony H; Farroh KY; Youssef T; Salaheldin TA
PLoS One; 2017; 12(7):e0181723. PubMed ID: 28746382
[TBL] [Abstract][Full Text] [Related]
4. Targeted polymeric nanoparticles for cancer gene therapy.
Kim J; Wilson DR; Zamboni CG; Green JJ
J Drug Target; 2015; 23(7-8):627-41. PubMed ID: 26061296
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors.
Nemunaitis J; Tong AW; Nemunaitis M; Senzer N; Phadke AP; Bedell C; Adams N; Zhang YA; Maples PB; Chen S; Pappen B; Burke J; Ichimaru D; Urata Y; Fujiwara T
Mol Ther; 2010 Feb; 18(2):429-34. PubMed ID: 19935775
[TBL] [Abstract][Full Text] [Related]
6. Prodrug converting enzyme gene delivery by L. monocytogenes.
Stritzker J; Pilgrim S; Szalay AA; Goebel W
BMC Cancer; 2008 Apr; 8():94. PubMed ID: 18402662
[TBL] [Abstract][Full Text] [Related]
7. Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer.
Nettelbeck DM
J Mol Med (Berl); 2008 Apr; 86(4):363-77. PubMed ID: 18214411
[TBL] [Abstract][Full Text] [Related]
8. Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.
van Gaal EV; Hennink WE; Crommelin DJ; Mastrobattista E
Pharm Res; 2006 Jun; 23(6):1053-74. PubMed ID: 16715361
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional Targeting in Cancer Gene Therapy.
Robson T; Hirst DG
J Biomed Biotechnol; 2003; 2003(2):110-137. PubMed ID: 12721516
[TBL] [Abstract][Full Text] [Related]
10. Targeting gene expression of the mouse uroplakin II promoter to human bladder cells.
Zhu H; Zhang ZA; Xu C; Huang G; Zeng X; Wei S; Zhang Z; Guo Y
Urol Res; 2003 Mar; 31(1):17-21. PubMed ID: 12624658
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.
Shibata T; Giaccia AJ; Brown JM
Neoplasia; 2002; 4(1):40-8. PubMed ID: 11922390
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of interleukin-2 and a vaccine of irradiated melanoma cells transfected to secrete staphylococcal enterotoxin A.
Schrayer DP; Kouttab N; Hearing VJ; Wanebo HJ
Clin Exp Metastasis; 2002; 19(1):43-53. PubMed ID: 11918082
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy for malignant melanoma.
Brown CK; Kirkwood JM
Curr Oncol Rep; 2001 Jul; 3(4):344-52. PubMed ID: 11389820
[TBL] [Abstract][Full Text] [Related]
14. Reporter gene vectors and assays.
Schenborn E; Groskreutz D
Mol Biotechnol; 1999 Nov; 13(1):29-44. PubMed ID: 10934520
[TBL] [Abstract][Full Text] [Related]
15. Targeted gene transfer for adenocarcinoma using a combination of tumor-specific antibody and tissue-specific promoter.
Kurane S; Krauss JC; Watari E; Kannagi R; Chang AE; Kudoh S
Jpn J Cancer Res; 1998 Nov; 89(11):1212-9. PubMed ID: 9914791
[TBL] [Abstract][Full Text] [Related]
16. Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local anti-tumour response, but induces T-cell-dependent systemic immunity only against B7-expressing tumours.
Chong H; Hutchinson G; Hart IR; Vile RG
Br J Cancer; 1998 Oct; 78(8):1043-50. PubMed ID: 9792148
[TBL] [Abstract][Full Text] [Related]
17. Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma.
Diaz RM; Eisen T; Hart IR; Vile RG
J Virol; 1998 Jan; 72(1):789-95. PubMed ID: 9420288
[TBL] [Abstract][Full Text] [Related]
18. Liposome mediated gene transfer into the rat oesophagus.
Schmid RM; Weidenbach H; Draenert GF; Liptay S; Lührs H; Adler G
Gut; 1997 Oct; 41(4):549-56. PubMed ID: 9391258
[TBL] [Abstract][Full Text] [Related]
19. Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues.
Takakuwa K; Fujita K; Kikuchi A; Sugaya S; Yahata T; Aida H; Kurabayashi T; Hasegawa I; Tanaka K
Jpn J Cancer Res; 1997 Feb; 88(2):166-75. PubMed ID: 9119745
[TBL] [Abstract][Full Text] [Related]
20. Targeted vectors for gene therapy of cancer and retroviral infections.
Walther W; Stein U
Mol Biotechnol; 1996 Dec; 6(3):267-86. PubMed ID: 9067974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
